We are open and ready for business!
Since its establishment in 2005, Al-Tareq Scientific Bureau has been dedicated to advancing Iraq’s healthcare sector by ensuring accessible, high-quality pharmaceutical products. Starting with partnerships in Syria, Al-Tareq imported vital drugs and medical supplies to meet the growing needs of the Iraqi market. This commitment to expanding access to essential medicines continued in 2014 when the bureau launched its second international partnership with an Egyptian pharmaceutical company. By 2017, Al-Tareq further broadened its reach by importing drugs from Turkey, strengthening its presence in Iraq's pharmaceutical landscape.
In recent years, Al-Tareq has taken strategic steps to secure long-term, reliable partnerships, including a major contract with an Indian manufacturer in 2023 to supply infusion products. This partnership supports the bureau's mission of ensuring affordability and quality, with a continued focus on finding sustained suppliers who can meet Iraq’s demand for reliable drug and medical supply sources.
Al-Tareq Scientific Bureau’s history reflects a relentless drive to provide affordable healthcare solutions and reduce market monopolies. Our pricing strategy is designed to offer medicines at consistent, fair prices, which is crucial in minimizing the economic burden on patients. Through transparent pricing and a trusted supply chain, we’re setting a new standard in Iraq's pharmaceutical market—one that values both accessibility and equity.
With a deep commitment to the future, we remain open and ready to serve, providing the highest quality products at fair prices to healthcare providers and patients across Iraq. Join us in our journey to transform Iraq’s healthcare landscape, making essential medicines available to all.
Our History
2005
The company started importing drugs & medical supplies from a Syrian pharmaceutical companies
2014
The company started their second abroad business by importing drugs from an Egyptian pharmaceutical company
2017
The company started its third abroad business by importing drugs from a Turkish pharmaceutical company
2023
The company had a long-term contract with an Indian manufacturer company for supplying infusion products.
2021
The company is looking for a sustained supplier who can fulfill our market requirements such as drugs & medical supplies